TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,125.00
+55.00 (1.79%)
Apr 1, 2025, 3:30 PM KST

TELCON RF PHARMACEUTICAL. Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
37,86536,30727,83037,84133,141
Upgrade
Other Revenue
--0--0-
Upgrade
Revenue
37,86536,30727,83037,84133,141
Upgrade
Revenue Growth (YoY)
4.29%30.46%-26.46%14.18%-41.44%
Upgrade
Cost of Revenue
27,62826,80022,26728,78025,905
Upgrade
Gross Profit
10,2379,5075,5639,0617,236
Upgrade
Selling, General & Admin
6,2524,4844,5546,9497,391
Upgrade
Research & Development
722.94733.171,2081,6351,817
Upgrade
Other Operating Expenses
112.5459.7668.03168.353.62
Upgrade
Operating Expenses
10,3078,5429,62613,6249,326
Upgrade
Operating Income
-70.55965.32-4,063-4,563-2,090
Upgrade
Interest Expense
-3,760-603.58-1,063-7,702-2,849
Upgrade
Interest & Investment Income
324.97205.0561.4245.4857.21
Upgrade
Earnings From Equity Investments
-24,684469.53-17,868-13,196-39,204
Upgrade
Currency Exchange Gain (Loss)
602.71119.08318.02831.71178.36
Upgrade
Other Non Operating Income (Expenses)
1,119-837.92-1,98177.32-135.85
Upgrade
EBT Excluding Unusual Items
-26,468317.48-24,595-24,507-44,042
Upgrade
Impairment of Goodwill
-----4,179
Upgrade
Gain (Loss) on Sale of Investments
1,27513,466-13,1464,6269,010
Upgrade
Gain (Loss) on Sale of Assets
17.27-14.834.3810.31-179.33
Upgrade
Asset Writedown
-1,097-64.8-4,411-3,005-51.13
Upgrade
Other Unusual Items
-227.31244.63---2,209
Upgrade
Pretax Income
-26,50013,949-42,117-22,875-41,652
Upgrade
Income Tax Expense
----18.95
Upgrade
Earnings From Continuing Operations
-26,50013,949-42,117-22,875-41,671
Upgrade
Earnings From Discontinued Operations
----331.42-355.73
Upgrade
Net Income to Company
-26,50013,949-42,117-23,207-42,027
Upgrade
Minority Interest in Earnings
180.11-42.3432.81108.81,134
Upgrade
Net Income
-26,32013,906-42,084-23,098-40,893
Upgrade
Net Income to Common
-26,32013,906-42,084-23,098-40,893
Upgrade
Shares Outstanding (Basic)
12111199
Upgrade
Shares Outstanding (Diluted)
12151499
Upgrade
Shares Change (YoY)
-20.89%8.89%56.33%2.65%3.29%
Upgrade
EPS (Basic)
-2224.631243.94-3967.18-2629.30-4778.04
Upgrade
EPS (Diluted)
-2225.001025.12-3967.18-2629.30-4781.56
Upgrade
Free Cash Flow
-3,749-4,954-2,912-2,6131,671
Upgrade
Free Cash Flow Per Share
-316.87-331.29-212.06-297.40195.25
Upgrade
Gross Margin
27.03%26.19%19.99%23.95%21.83%
Upgrade
Operating Margin
-0.19%2.66%-14.60%-12.06%-6.31%
Upgrade
Profit Margin
-69.51%38.30%-151.22%-61.04%-123.39%
Upgrade
Free Cash Flow Margin
-9.90%-13.64%-10.46%-6.90%5.04%
Upgrade
EBITDA
4,4365,210218.47-363.072,307
Upgrade
EBITDA Margin
11.72%14.35%0.78%-0.96%6.96%
Upgrade
D&A For EBITDA
4,5074,2444,2814,2004,397
Upgrade
EBIT
-70.55965.32-4,063-4,563-2,090
Upgrade
EBIT Margin
-0.19%2.66%-14.60%-12.06%-6.31%
Upgrade
Advertising Expenses
35.0610.7745.183.3618.62
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.